David Shaw’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $495K | Buy |
+58,400
| New | +$389K | ﹤0.01% | 4185 |
|
|
2025
Q4 | – | Sell |
-50,200
| Closed | -$388K | – | 5002 |
|
|
2025
Q3 | $388K | Hold |
50,200
| – | – | ﹤0.01% | 3989 |
|
|
2025
Q2 | $437K | Hold |
50,200
| – | – | ﹤0.01% | 3701 |
|
|
2025
Q1 | $400K | Sell |
50,200
-100,000
| -67% | -$1.01M | ﹤0.01% | 3614 |
|
|
2024
Q4 | $1.37M | Hold |
150,200
| – | – | ﹤0.01% | 3012 |
|
|
2024
Q3 | $1.38M | Buy |
+150,200
| New | +$1.24M | ﹤0.01% | 3016 |
|
|
2024
Q1 | – | Sell |
-361,000
| Closed | -$7.78M | – | 4729 |
|
|
2023
Q4 | $7.78M | Hold |
361,000
| – | – | 0.01% | 1566 |
|
|
2023
Q3 | $6.71M | Sell |
361,000
-72,400
| -17% | -$1.69M | 0.01% | 1570 |
|
|
2023
Q2 | $11M | Sell |
433,400
-235,000
| -35% | -$5.91M | 0.01% | 1267 |
|
|
2023
Q1 | $17.3M | Sell |
668,400
-98,100
| -13% | -$2.63M | 0.02% | 987 |
|
|
2022
Q4 | $18.1M | Sell |
766,500
-82,700
| -10% | -$2.23M | 0.02% | 991 |
|
|
2022
Q3 | $21.5M | Buy |
849,200
+250,300
| +42% | +$8.78M | 0.03% | 806 |
|
|
2022
Q2 | $19.9M | Buy |
598,900
+103,900
| +21% | +$4.41M | 0.02% | 874 |
|
|
2022
Q1 | $35.7M | Buy |
495,000
+30,200
| +6% | +$2.18M | 0.03% | 653 |
|
|
2021
Q4 | $42.7M | Buy |
464,800
+261,800
| +129% | +$31.3M | 0.04% | 630 |
|
|
2021
Q3 | $25.7M | Sell |
203,000
-18,400
| -8% | -$2.68M | 0.02% | 868 |
|
|
2021
Q2 | $36.8M | Buy |
221,400
+47,700
| +27% | +$7.73M | 0.03% | 693 |
|
|
2021
Q1 | $31.6M | Buy |
173,700
+74,363
| +75% | +$17.2M | 0.03% | 694 |
|
|
2020
Q4 | $19.9M | Sell |
99,337
-60,763
| -38% | -$12.4M | 0.02% | 959 |
|
|
2020
Q3 | $35.1M | Buy |
160,100
+91,600
| +134% | +$19.4M | 0.04% | 557 |
|
|
2020
Q2 | $13.1M | Buy |
68,500
+18,500
| +37% | +$3.24M | 0.02% | 1038 |
|
|
2020
Q1 | $7.75M | Buy |
50,000
+45,000
| +900% | +$5.24M | 0.01% | 1147 |
|
|
2019
Q4 | $419K | Hold |
5,000
| – | – | ﹤0.01% | 3485 |
|
|
2019
Q3 | $339K | Hold |
5,000
| – | – | ﹤0.01% | 3393 |
|
|
2019
Q2 | $332K | Hold |
5,000
| – | – | ﹤0.01% | 3272 |
|
|
2019
Q1 | $278K | Sell |
5,000
-3,600
| -42% | -$220K | ﹤0.01% | 3255 |
|
|
2018
Q4 | $426K | Sell |
8,600
-3,200
| -27% | -$196K | ﹤0.01% | 3181 |
|
|
2018
Q3 | $1.02M | Buy |
11,800
+8,200
| +228% | +$584K | ﹤0.01% | 2693 |
|
|
2018
Q2 | $209K | Buy |
+3,600
| New | +$176K | ﹤0.01% | 3543 |
|
Other funds holding TDOC
VC
David Shaw's TDOC Position: Q2 2026 in Review
David Shaw reduced its Teladoc Health (TDOC) stake by 6.2% in Q2 2026, selling an estimated $279K and leaving 639,209 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2332.
David Shaw first reported a position in TDOC in Q1 2016 and has held it in 29 quarters since. The position peaked at $76.6M in Q3 2022. 345 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.
- David Shaw held 639,209 shares of Teladoc Health worth $5.42M as of Q2 2026.
- David Shaw sold 41,950 Teladoc Health shares in Q2 2026, an estimated $279K.
- Teladoc Health made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2332 holding.
- David Shaw first reported a position in Teladoc Health in Q1 2016 and has held it in 29 quarters since.
- David Shaw's Teladoc Health position peaked at $76.6M in Q3 2022.
- 345 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.